Latest 8-K filings

The RealReal announces a new $150 million term loan and $25 million revolving credit facility to redeem its 2029 Notes, extending debt maturity and reducing interest expense.

ASP Isotopes Inc. announces a binding Heads of Agreement with Necsa to establish a joint venture for High-Assay Low-Enriched Uranium (HALEU) production in South Africa.

CCC Intelligent Solutions Holdings Inc. has entered into a definitive agreement to be acquired by GTCR and Elliott Investment Management in an all-cash transaction valued at approximately $6.1 billion.

Marsh & McLennan Companies announced robust third quarter 2026 financial results, featuring 8% revenue growth and a 10% increase in adjusted EPS.

FMC Corporation announced a significant downward revision to its third-quarter expectations, now anticipating substantially lower revenue and negative Adjusted EBITDA, alongside substantial charges for comprehensive commercial actions.

Commercial Metals Company announced robust fourth quarter and full year fiscal 2026 financial results, driven by strong performance in its North America Steel Group, successful precast operations integration, and benefits from its TAG program, while also achieving a net leverage ratio below its 2.0x target.

Ocugen provides an update on its gene therapy pipeline, detailing progress in Phase 3 trials for Retinitis Pigmentosa (OCU400) and Geographic Atrophy (OCU410), and Phase 2/3 for Stargardt Disease (OCU410ST), with multiple BLA submissions anticipated by 2028.

SurgePays, Inc. announced the addition of an updated investor presentation to its website, providing information about the company and its business.

Bank7 Corp. announced robust third quarter 2026 results, including a 22.25% increase in net income, and confirmed all approvals for its acquisition of Century Financial, expected to close November 1, 2026.

Jasper Therapeutics announced the completion of enrollment for the IgA nephropathy cohort in its Phase 2 study of vensobafusp alfa (KP104) and plans to dose the first FSGS patients in Q1 2027.

Valion Bio's subsidiary Velocity Bioworks successfully completed an initial feasibility evaluation of LarmorBio's BioScan-NMR platform, showing potential for real-time bioprocess monitoring.

ManpowerGroup announced robust third-quarter 2026 results, with revenues up 4% to $4.8 billion and net earnings soaring to $34.1 million, driven by broad-based strength.

The Allstate Corporation announced estimated catastrophe losses for September 2026 totaling $220 million, contributing to a substantial third-quarter total.

ManpowerGroup has announced a planned leadership transition with Rebecca Frankiewicz set to become CEO on January 1, 2027, succeeding Jonas Prising who will move to Executive Chair.

First Horizon Corporation reported a net loss of $94 million for the third quarter of 2026, largely due to a $473 million pre-tax loss from the strategic sale of approximately $4.5 billion in consumer mortgages.

Gibraltar Industries announces the sale of its Infrastructure business, D.S. Brown, to Saint-Gobain for $208 million in cash, as part of a strategic plan to simplify its portfolio and reduce debt.

Plug Power Inc. provided a business update for Q3 2026, indicating greater than 10% revenue growth, improved margins, and a record low net cash usage of approximately $28 million.

Aquestive Therapeutics announced the FDA has accepted its resubmission of the New Drug Application for Anaphylm, setting a PDUFA goal date of March 16, 2027.

Oaktree Acquisition Corp. III Life Sciences reports preliminary redemption results, with over 13.3 million Class A ordinary shares tendered for redemption.

Kimberly-Clark announced preliminary third quarter 2026 financial data, indicating a slight decrease in net sales and organic growth compared to the prior year, but reaffirmed its full-year 2026 outlook for Adjusted Operating Profit and Adjusted Earnings per Share.

MGP Ingredients, Inc. announced its rebranding to Sempreon, Inc., effective November 2, 2026, with a planned ticker symbol change to CASK, signaling a new corporate identity and strategic direction.

Krystal Biotech announced positive clinical data from its Gorlin Syndrome Pilot Study evaluating KB113, showing over 80% of assessed basal cell carcinoma lesions regressed.

Cronos Group Inc. has finalized the acquisition of CanAdelaar B.V., establishing a significant European platform in the Netherlands' adult-use cannabis pilot program.

J.W. Mays, Inc. announced the promotion of Kevin J. Guptar to Chief Financial Officer and Treasurer, succeeding the retiring Ward Lyke, Jr.

Tonix Pharmaceuticals Holding Corp. has disclosed preliminary operating results for the third quarter of 2026, estimating net revenue for TONMYA between $14.0 million and $15.0 million, and reporting approximately $162.8 million in cash and cash equivalents as of September 30, 2026.

Esquire Financial Holdings, Inc. has filed an amendment to its Form 8-K to supplement information regarding its combination with Signature Bancorporation, Inc., confirming the merger's completion and providing pro forma financial data.

i-80 Gold Corp. announced the posting of an updated corporate presentation on its website as of October 15, 2026.

U.S. Bancorp announced record net revenue of $7.97 billion and net income of $2.20 billion for the third quarter of 2026, demonstrating significant year-over-year growth.

Penske Automotive Group, Inc. has entered into a definitive agreement to be acquired by an entity owned by Penske Corporation and Mitsui & Co., Ltd. for approximately $16.3 billion.

Hamilton Lane announced a leadership evolution with Hartley Rogers appointed Co-CEO alongside Juan Delgado-Moreira, and Erik Hirsch transitioning to Executive Co-Chairman to focus on strategic initiatives.